By Business/Source
Currency:USD
2025/FY
Stock NameRevenueRatio
Other business262.97M47.94%
肿瘤╱免疫业务-上市产品214.36M39.08%
肿瘤╱免疫业务-研发71.18M12.98%
By Product
Currency:USD
2025/FY
Stock NameRevenueRatio
Other business262.97M47.94%
肿瘤╱免疫业务-上市产品214.36M39.08%
肿瘤╱免疫业务-研发71.18M12.98%
By Country/Region
Currency:USD
2025/FY
Stock NameRevenueRatio
China407.45M74.28%
美国及其他国家地区141.06M25.72%
